Inventor · disambiguated record
Zhi-Ming Ding
Also filed as: DING ZHI-MING
8 granted patents·3 pending applications·33 citations·filing 1995–2024
81Inventor score
Top patents by PatentIndex Score
11 records- 0192US11629349B2RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2022·Granted Apr 18, 2023·3 cites·14 claims
- 0292US11549112B1RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2022·Granted Jan 10, 2023·3 cites·14 claims
- 0386US11845937B2RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2023·Granted Dec 19, 2023·1 cites·22 claims
- 0479US12378558B2RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutical compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2024·Granted Aug 5, 2025·0 cites·19 claims
- 0576US2023139166A1RNAi Agents for Inhibiting Expression of Xanthine Dehydrogenase (XDH), Pharmaceutical Compositions Thereof, and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0676US2023125671A1RNAi Agents for Inhibiting Expression of Xanthine Dehydrogenase (XDH), Pharmaceutical Compositions Thereof, and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0775US2025034577A1RNAi Agents for Inhibiting Expression of PNPLA3, Pharmaceutical Compositions Thereof, and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0868US12503696B2RNAi agents for inhibiting expression of inhibin subunit beta E (INHBE), pharmaceutical compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2024·Granted Dec 23, 2025·0 cites·16 claims
- 0966US12442002B2RNAi agents for inhibiting expression of activin receptor-like kinase 7 (ALK7), compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2024·Granted Oct 14, 2025·0 cites·19 claims
- 1066US12054718B2RNAi agents for inhibiting expression of PNPLA3, pharmaceutical compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2021·Granted Aug 6, 2024·0 cites·34 claims
- 1159US5766899ATargeted nucleic acid delivery into liver cellsUNIV TEXAS·Filed 1995·Granted Jun 16, 1998·26 cites·29 claims
Join the waitlist — get patent alerts
Get an alert when Zhi-Ming Ding files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →